Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success (Q37806065)

23 August 2017

title

Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success (English)

1 reference

stem cell transplantation

23 August 2017

main subject

1 reference

D. P. Kontoyiannis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21042306

18 August 2024

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Bone Marrow Transplantation

23 August 2017

published in

1 reference

23 August 2017

volume

46

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

165-173

1 reference

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Fungal infections in transplant and oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician's viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Keratinocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Fungal infection prevention after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Breakthrough invasive fungal infection in an immunocompromised host while on posaconazole prophylaxis: an omission in patient counseling and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Antifungal therapeutic drug monitoring: established and emerging indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Plasminogen alleles influence susceptibility to invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Geoclimatic factors and invasive aspergillosis after allogeneic hematopoietic stem cell transplantation: new perspectives for patient management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Comparative cost-effectiveness of posaconazole versus fluconazole or itraconazole prophylaxis in patients with prolonged neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

TLR1 and TLR6 Polymorphisms Are Associated with Susceptibility to Invasive Aspergillosis after Allogeneic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 epression in monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038/BMT.2010.256

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.256

1 reference

23 August 2017

1 reference